enVVeno Medical (NVNO) EBT (2017 - 2026)

enVVeno Medical has reported EBT for 10 years, with the latest figure at -$3.8 million in Q2 2026.

• On a quarterly basis, EBT rose 44.75% year-over-year to -$3.8 million in Q2 2026; TTM through Jun 2026 was -$16.4 million, a 32.05% increase from a year earlier, with the FY2025 full-year figure at -$20.2 million, up 13.78% from the prior year.
• EBT was -$3.8 million for Q2 2026 at enVVeno Medical, up from -$4.0 million in the prior quarter.
• The five-year high for EBT was -$3.8 million in Q2 2026, with the low at -$6.9 million in Q2 2022.
• Average EBT over 5 years is -$5.6 million, with a median of -$5.8 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: EBT plunged 191.99% in 2022, then jumped 44.75% in 2026.
• Over 5 years, EBT stood at -$6.4 million in 2022, then gained by 2.96% to -$6.2 million in 2023, then declined by 4.98% to -$6.5 million in 2024, then jumped by 40.18% to -$3.9 million in 2025, then gained by 3.15% to -$3.8 million in 2026.
• The last three EBT figures came in at -$3.8 million (Q2 2026), -$4.0 million (Q1 2026), and -$3.9 million (Q4 2025), per Business Quant data.